news release
December 21, 2023
World Intellectual Property Organization (WIPO) published International Patent Application: Composition of a Lipophilic Agent for Solution Phase Synthesis of Biomolecules.
International Publication Number: WO2023/244274A2.
November 23, 2023
United States Patent and Trademark Office (USPTO) published US Patent Application: Composition of a Lipophilic Agent for Solution Phase Synthesis of Biomolecules.
Publication Number: US2023/0373936A1.
Biotide Core attends 28th American Peptide Symposium in Scottsdale, Arizona, USA.
Poster: Cyclophase synthesis, a productive process for peptide manufacturing (ID # P114)
Christina Uth, Simon Englert, Olga Avrutina, Harald Kolmar, Sascha Knauer
Journal of Peptide Science 2023, e3527.
Methods and Protocols 2022, 5(5), 72.
May 19, 2022
Patent application for Cyclover was filed. Pure compound anchored to Cyclover can be reproducibly obtained from reaction mixture by rapid crystallization with ease and certainty. Cyclophase synthesis offers a most productive process which can expedite the development of a drug from bench to batch.
Damilola C. Akintayo, Beatriz G. de la Torre, Yongfu Li, Fernando Albericio
Amino-Li-Resin, A Fiber Polyacrylamide Resin for Solid-Phase Peptide Synthesis
August 1, 2020
Biotide Core, LLC moved into Eastgate Research and Development Facility in Corvallis, Oregon.
June 29, 2020
Biotide Core, an Oregon Domestic Limited-Liability Company set up.